NeXtGen Biologics ™

Patented, FDA-cleared, novel wound-care technology | New skin in the game!

Print
Claim My Business
Form C
View on Republic
Security Type
Crowd SAFE
Min Investment
$250
Location
ALACHUA, FL
Offering Date
September 02, 2022
Expected Close Date
February 28, 2023
Target Raise
$25.00K-$5.00M
No. Investors
347
Security Price
$1
Website
nextgenbiologics.com
Number of Employees
9
Cash
$337,233
Revenue
$0
Short Term Debt
$9,761,500
Cost of Goods
$0
Long Term Debt
$0
Net Income
$-2,007,144

Company Description

The Extracellular Matrix (ECM) is a large, three-dimensional network of proteins and other molecules important to cell functions and plays a major role in health and disease6 through repairing damaged tissue.7 Available for decades, ECM products have been used to address many complex conditions seen in wounds (chronic and acute such as burns), general surgery, trauma, plastic surgery, cardiovascular and gastrointestinal diseases, neurosurgery, orthopedics, and ophthalmology.

Key Deal Facts

ECM technology derived from the axolotl, a regenerative species
Researching scar-free healing & restored function
Platform-based technology for a wide range of complex conditions
FDA-cleared, patent issued
Nearly $14M raised to date

Management Team / Advisory Board Bios

Jonelle Toothman
CEO and Co-Founder

Jamie Grooms
Chairman of the Board & Co-Founder

Gerald Kluft
Director

Sherrick Wassel
Director

Elad Levy, MD
Director

Brian Lipke
Director

Dan Hamister
Director
Amount Raised : $241,925
Reveal the Score by Voting
＿
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
ⓘ
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
ⓘ
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
ⓘ
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
ⓘ
The value of the company compared to similar companies raising money from investors.
Valuation

Security Description

An equity crowdfunding specific version of a SAFE used by crowdfunding portal Republic. Upon conversion (if and when that happens), investors may receive special shares with limited rights that do not show up on a company’s cap table. The issuer may roll over and not convert shares at the next financing round causing investors to lose out on some upside.

Research Reports

No reports have been submitted

Become a Reporter
Read Our Research Disclaimer

0 Comments

Post Comment